The Department of Hepatobiliary is the leading unit of the National “Twelfth Five-Year Plan” for major infectious diseases and the construction unit of the National GCP platform for clinical drug trials of liver diseases; The department has a research laboratory of liver disease, which is Jilin provincial liver disease research institute; a testing base of clinical medicine, which undertakes domestic and international multi-research center projects, conducts medicine clinical trials, which ranks the top in quantity in China and has played an essential role in promoting the progress of liver disease treatment. The total accumulated scientific research funding of the department is over 100 million RMB, ranking among the top in the Health Science Center of Jilin University; It is the publishing unit of the national scientific and technological journal: Journal of Clinical Hepatobiliary Diseases, which is the earliest professional journal of hepatobiliary diseases established in China and currently ranks the top in the field of digestive system diseases.

There are a total of 32 doctors in the department, including 13 seniors, 5 associate seniors, 5 doctoral supervisors, 13 master supervisors, 5 full-time scientific researchers.